Most adults with moderate-to-severe ulcerative colitis may be ineligible for randomized controlled trials

More than half of real-world adult patients with moderate-to-severe ulcerative colitis (UC) are ineligible for current randomized controlled trials (RCTs), according to a study published online Aug. 4 in Crohn's & Colitis 360.